Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990-2003

Vaccine

Volumn 26, Issue 9, 2008, Pages 1166-1172

  Asatryan, Armenak ^a   Pool, Vitali ^b   Chen, Robert T ^b   Kohl, Katrin S ^b   Davis, Robert L ^b   Iskander, John K ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Hearing loss; Measles; MMR; Mumps; Vaccine

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES MUMPS VACCINE; MEASLES VACCINE; MMR II; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; INCUBATION TIME; MEASLES VACCINATION; MEASLES VIRUS; MEDICAL LITERATURE; MUMPS VIRUS; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PUBLICATION; UNITED STATES; VIRUS STRAIN;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HEARING LOSS; HUMANS; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MIDDLE AGED; MUMPS; MUMPS VACCINE; VACCINATION; VACCINES, ATTENUATED; VACCINES, COMBINED;

EID: 39149117016     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.12.049     Document Type: Article

References (42)

1. Van Naarden K., Decoufle P., and Caldwell K. Prevalence and characteristics of children with serious hearing impairment in metropolitan Atlanta, 1991-1993. Pediatrics 103 March (3) (1999) 570-575
2. Drews C.D., Yeargin-Allsopp M., Murphy C.C., and Decoufle P. Hearing impairment among 10-year-old children: metropolitan Atlanta, 1985 through 1987. Am J Public Health 84 July (7) (1994) 1164-1166
3. Van Dishoeck H.A., and Bierman T.A. Sudden perceptive deafness and viral infection; report of the first one hundred patients. Ann Otol Rhinol Laryngol 66 (1957) 963-980
4. Pappas D.G., and Mundy M.R. Sensorineural hearing loss: infectious agents. Laryngoscope 92 (1982) 752-754
5. Alberti P.W. The prevention of hearing loss worldwide. Scand Audiol Suppl 42 (1996) 15-19
6. Johnston P.W. Factors associated with deafness in young children. Public Health Rep 82 (1967) 1019-1024
7. Kinney C.E. Hearing impairments in children. Laryngoscope 63 (1953) 220-226
8. McKenna M.J. Measles, mumps, and sensorineural hearing loss. Ann NY Acad Sci 830 (1997) 291-298
9. Tarkkanen J., and Aho J. Unilateral deafness in children. Acta Otolaryngol 61 (1966) 270-278
10. Everberg G. Deafness following mumps. Acta Otolaryngol 48 (1957) 397-403
11. Hall R., and Richards H. Hearing loss due to mumps. Arch Dis Child 62 (1987) 189-191
12. Kayan A., and Bellman H. Bilateral sensorineural hearing loss due to mumps. Br J Clin Pract 44 (1990) 757-759
13. Lindsay J.R., Davey P.R., and Ward P.H. Inner ear pathology in deafness due to mumps. Ann Otol Rhinol Laryngol 69 (1960) 918-935
14. Mandell G.L. Principles and practice of infectious diseases (2000), Churchill Livingstone, New York
15. In: Stratton K.R., Howe C.J., and Johnston R.B. (Eds). Adverse events associated with childhood vaccines (1994), National Academy Press, Washington, DC
16. Strebel P.M. Measles. Bull World Health Organ 76 Suppl. 2 (1998) 154-155
17. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines (2004), Saunders, Philadelphia
18. Centers for Disease Control and Prevention (CDC). Measles, Mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998; 47(RR-8): 1-57.
19. Bloom S., Smith P., Stanwyck C., and Stokley S. Has the United States population been adequately vaccinated to achieve rubella elimination?. Clin Infect Dis 43 1, November (Suppl. 3) (2006) S141-S145
20. Chen R.T., Rastogi S.C., Mullen J.R., Hayes S.W., Cochi S.L., Donlon J.A., et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 12 (1994) 542-550
21. Brodsky L., and Stanievich J. Sensorineural hearing loss following live measles virus vaccination. Int J Pediatr Otorhinolaryngol 10 (1985) 159-163
22. Hayden G.F., Preblud S.R., Orenstein W.A., and Conrad J.L. Current status of mumps and mumps vaccine in the United States. Pediatrics 62 (1978) 965-969
23. Healy C.E. Mumps vaccine and nerve deafness. Am J Dis Child 123 (1972) 612
24. Hulbert T.V., Larsen R.A., Davis C.L., and Holtom P.D. Bilateral hearing loss after measles and rubella vaccination in an adult. N Eng J Med 325 (1991) 134
25. Jayarajan V., and Sedler P.A. Hearing loss following measles vaccination. J Infect 30 (1995) 184-185
26. Kaga K., Ichimura K., and Ihara M. Unilateral total loss of auditory and vestibular function as a complication of mumps vaccination. Int J Pediatr Otorhinolaryngol 43 (1998) 73-75
27. Koga K., Kawashiro N., Araki A., and Watanabe M. Bilateral acute profound deafness after MMR vaccination-report of a case. Nippon Jibiinkoka Gakkai Kaiho 94 (1991) 1142-1145
28. Nabe-Nielsen J., and Walter B. Unilateral deafness as a complication of the mumps, measles, and rubella vaccination. BMJ 297 (1988) 489
29. Nabe-Nielsen J., and Walter B. Unilateral total deafness as a complication of the measles-mumps-rubella vaccination. Scand Audiol Suppl 30 (1988) 69-70
30. Stewart B.J., and Prabhu P.U. Reports of sensorineural deafness after measles, mumps, and rubella immunisation. Arch Dis Child 69 (1993) 153-154
31. Watson J.G. A child of 3 years who developed an encephalitic reaction to MMR (mumps, measles, rubella) immunisation at age 15 months. Int J Pediatr Otorhinolaryngol 19 (1990) 189-190
32. Markowitz L.E., Tomasi A., Sirotkin B.I., Carr R.W., Davis R.M., Preblud S.R., et al. Measles hospitalizations, United States, 1977-84: comparison with national surveillance data. Am J Public Health 77 (1987) 866-868
33. Nolan Jr. T.F., Goodman R.A., Patriarca P.A., and Hinman A.R. Hospitalizations for measles, 1970-78. Am J Public Health 72 (1982) 1037-1039
34. Singleton J.A., Lloyd J.C., Mootrey G.T., Salive M.E., and Chen R.T. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. Vaccine 17 (1999) 2908-2917
35. Watson J.C., Hadler S.C., Dykewicz C.A., Reef S., and Phillips L. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 47 (1998) 1-57
36. Centers for Disease Control and Prevention (CDC). National, state, and urban area vaccination coverage among children aged 19-35 months-United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53: 658-61.
37. Allred N.J., Shaw K.M., Santibanez T.A., Rickert D.L., and Santoli J.M. Parental vaccine safety concerns: results from the National Immunization Survey, 2001-2002. Am J Prev Med 28 February (2) (2005) 221-224
38. Gust D.A., Strine T.W., Maurice E., Smith P., Yusuf H., Wilkinson M., et al. Underimmunization among children: effects of vaccine safety concerns on immunization status. Pediatrics 114 July (1) (2004) e16-e22
39. Ehresmann K.R., Crouch N., Henry P.M., Hunt J.M., Habedank T.L., Bowman R., et al. An outbreak of measles among unvaccinated young adults and measles seroprevalence study: implications for measles outbreak control in adult populations. J Infect Dis 189 1, May (Suppl. 1) (2004) S104-S107
40. Williams W.W., Sosin D.M., Kaplan K.M., Hersh B.S., and Preblud S.R. Vaccine-preventable diseases on college campuses: the emergence of mumps. J Am Coll Health 37 March (5) (1989) 197-203
41. Arnold W., Busch R., Arnold A., Ritscher B., Neiss A., and Niedermeyer H.P. The influence of measles vaccination on the incidence of otosclerosis in Germany. Eur Arch Otorhinolaryngol (2007, February 13) [Epub ahead of print]
42. Centers for Disease Control and Prevention (CDC). Progress toward measles elimination-region of the Americas, 2002-2003. MMWR Morb Mortal Wkly Rep 2004;53: 304-6.